Project Grant HT94252410812
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
This Project Grant award of $717,896.00 was provided by the Defense Health Agency to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420). The purpose of the award is to conduct research on prebiotic and probiotic interventions for the treatment of traumatic brain injury (TBI)-induced microbiome dysfunction. The Ohio State University is the prime awardee, and they have issued a $XXX,XXX subaward to the Research Institute at Nationwide Children's...
The federal Project Grant award of $757,521.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to Oregon State University (OSU) for the project "IMPACT OF THE GUT MICROBIOTA ON GUT SENSORY NEUROCIRCUITS IN AUTISM SPECTRUM DISORDER". The award, which runs from July 1, 2025 to June 30, 2028, supports advanced biomedical research focused on transforming healthcare for military service members and the public. The project...
The Oregon Health & Science University (OHSU) was awarded a $644,570 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund the TBI Exosomal Activity in Military Personnel: Perivascular Space and Role of Indicators of Sleep Metrics (TEAM-PRISM) project. Through this funding, OHSU researchers will investigate medical solutions for traumatic brain injury on the battlefield by exploring the role...
This federal Project Grant award for $7,700,740.00 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The funding supports a 4-year research project titled "CONSEQUENCES OF BRAIN INJURY ON GLIA-NEURON DYNAMICS, NEUROPATHOLOGY, AND NEUROPSYCHIATRIC ILLNESS" aimed at investigating the effects of brain injury on glial-neuronal interactions, neuropathology, and neuropsychiatric conditions. The...
The Defense Health Agency awarded a $725,000 Project Grant to the University of Oklahoma Health Sciences Center to develop treatments for cognitive, motor, and sensory outcomes associated with mild traumatic brain injury and post-traumatic stress disorder. Funded through the Military Medical Research and Development program under the Cooperative Agreements and Other Transactions authority, this three-year award beginning April 15, 2023 will support research into modulating the NOP receptor...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $999,823 Project Grant to Oregon Health & Science University (OHSU) on June 1, 2024. The grant, titled "TARGETING NEURODEGENERATION IN THE AGED DEMYELINATED CNS," supports OHSU's biomedical research efforts to investigate innovative treatments for neurological disorders. Through this funding, OHSU will conduct basic, applied, and advanced research to develop new medical...
The Washington University Office of Sponsored Research Services Division was awarded a $1,377,119 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct the study "AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI" over a 4-year period from September 2024 to September 2028. This federal grant supports innovative biomedical research aimed at improving health outcomes for military service...
The federal Project Grant award of $718,829.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research conducted by Brigham & Women's Hospital Inc. (a subsidiary of Partners Healthcare System Incorporated) to investigate the use of the compounds ergothioneine and ovothiol A as potential treatments for traumatic brain injury and comorbid alcohol use disorder. The research aims to advance disease...
The Oregon Health & Science University was awarded a $249,308 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2021 through March 31, 2024. The grant aims to support research titled "IANAM: THE ABILITY TO "VISUALIZE" HEADACHE, SLEEP DISTURBANCE, AND MTBI" which investigates medical solutions for conditions experienced by military service members, such as traumatic brain...
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...